Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Conditions:   Pulmonary Disease;   Tuberculosis, Pulmonary;   Tuberculosis;   Multi Drug Resistant Tuberculosis;   Drug Sensitive Tuberculosis;   Drug-resistant Tuberculosis;   Mycobacterium Tuberculosis Infection Interventions:   Drug: TBAJ-876 10mg;   Drug: TBAJ-876 25mg;   Drug: TBAJ-876 50mg;   Drug: TBAJ-876 100mg;   Drug: TBAJ-876 200mg;   Drug: TBAJ-876 400mg;   Drug: TBAJ-876 Dose XXXmg for Food cohort;   Drug: TBAJ-876 XXXmg for Part 2;   Drug: Matching Placebo for TBAJ-876 tab let Sponsor:   Global Alliance for TB Drug Development Recruiting

Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials